David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Orthofix Medical
OFIX
$388M
| $376K | ﹤0.01% |
20,810
-54,506
| -72% | -$1.02M |
|
3402
Eldorado Gold
EGO
$12.4B
| $375K | ﹤0.01% |
+37,120
| New | +$393K |
|
3403
Amcor
AMCR
$21.9B
| $375K | ﹤0.01% |
7,506
-28,314
| -79% | -$1.48M |
|
3404
Home BancShares
HOMB
$5.98B
| $372K | ﹤0.01% |
16,331
-14,621
| -47% | -$319K |
|
3405
Sportsman's Warehouse
SPWH
$44.5M
| $372K | ﹤0.01% |
65,272
-208,076
| -76% | -$1.25M |
|
3406
TransDigm Group
TDG
$65.5B
| $370K | ﹤0.01% |
414
| – | – |
|
|
AEVA
3407
Aeva Technologies
AEVA
$1.14B
| $368K | ﹤0.01% |
58,800
+50,543
| +612% | +$288K |
|
|
HIBB
3408
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $367K | ﹤0.01% |
10,113
-33,721
| -77% | -$1.61M |
|
3409
Anavex Life Sciences
AVXL
$330M
| $367K | ﹤0.01% |
+45,104
| New | +$387K |
|
|
IRRX.WS
3410
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
| $367K | ﹤0.01% |
940,000
| – | – |
|
3411
Mizuho Financial
MFG
$126B
| $366K | ﹤0.01% |
119,176
-247,895
| -68% | -$736K |
|
3412
New Mountain Finance
NMFC
$715M
| $365K | ﹤0.01% |
29,315
+7,458
| +34% | +$90K |
|
|
CCRN
3413
DELISTED
Cross Country Healthcare
CCRN
| $362K | ﹤0.01% |
+12,900
| New | +$320K |
|
3414
ALX Oncology
ALXO
$278M
| $362K | ﹤0.01% |
48,207
+7,132
| +17% | +$46.7K |
|
3415
PetMed Express
PETS
$38.2M
| $361K | ﹤0.01% |
+26,185
| New | +$393K |
|
|
IPXXU
3416
DELISTED
Inflection Point Acquisition Corp. II Unit
IPXXU
| $360K | ﹤0.01% |
+35,600
| New | +$360K |
|
3417
Grupo Cibest SA
CIB
$24B
| $359K | ﹤0.01% |
+13,453
| New | +$351K |
|
3418
John B. Sanfilippo & Son
JBSS
$880M
| $359K | ﹤0.01% |
3,060
| – | – |
|
3419
Dell
DELL
$293B
| $356K | ﹤0.01% |
6,570
-14,161
| -68% | -$652K |
|
3420
NMI Holdings
NMIH
$3.41B
| $354K | ﹤0.01% |
+13,700
| New | +$332K |
|
3421
Twilio
TWLO
$34.5B
| $352K | ﹤0.01% |
5,537
-235,633
| -98% | -$13.9M |
|
3422
Ovid Therapeutics
OVID
$566M
| $352K | ﹤0.01% |
107,282
-231,878
| -68% | -$787K |
|
3423
Royal Gold
RGLD
$22.5B
| $351K | ﹤0.01% |
3,057
-843
| -22% | -$108K |
|
3424
FerroAtlántica
GSM
$753M
| $351K | ﹤0.01% |
73,543
-313,476
| -81% | -$1.44M |
|
3425
ReNew
RNW
$2.48B
| $350K | ﹤0.01% |
63,954
-47,605
| -43% | -$261K |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.